- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ATAI Beckley Inc (ATAI)
The ATAI Beckley share price today is 7.365, view NASDAQ ATAI stock exchange data. Track the latest ATAI Beckley share price with real-time updates on ATAI stock performance including market cap, day range, 52-week range and dividend yield. Access ATAI charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.270
7.370
52 wk Range
3.265
7.370
Earnings results expected today
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.2707.370
52 wk Range
3.2657.370
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ATAI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
8.100
Upside
+10.13%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
- Atai stock hits 52-week high of $7.26
- Investing.com
Atai stock hits 52-week high at 7.22 USD- Investing.com
- Atai stock hits 52-week high of $7.26
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
13 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 8.100
(+10.13% Upside)
Earnings
Latest Release
19-08-2026
EPS / Forecast
-0.09 / -0.12
Revenue / Forecast
1.7M / 140K
Compare ATAI to Peers and Sector
Metrics to compare | ATAI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATAIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.1x | −5.1x | −0.3x | |
PEG Ratio | 0.02 | 0.04 | 0.00 | |
Price/Book | 15.4x | 2.3x | 2.6x | |
Price / LTM Sales | 607.9x | 2.4x | 3.1x | |
Upside (Analyst Target) | 9.7% | 59.0% | 50.4% | |
Fair Value Upside | Unlock | 0.1% | 6.4% | Unlock |
AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic for the treatment of major depressive disorder. It is also developing VLS-01, an oral transmucosal film formulation of N,N-Dimethyltryptamine in Phase 2 clinical study to treat TRD; EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine that is in Phase 2 clinical study for social anxiety disorder; and EGX-A & EGX-B, which are non-hallucinogenic 5-HT2A receptor agonists for TRD. In addition, the company offers COMP360 for psilocybin therapy; and GRX-917 for the treatment of anxiety, depression, and various neurological disorders. The company was formerly known as Atai Beckley N.V. and changed its name to AtaiBeckley Inc. in December 2025. AtaiBeckley Inc. was founded in 2018 and is based in New York, New York.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the ATAI Beckley (ATAI) Share Price Today?
The ATAI Beckley share price today is 7.355.
What is the current ATAI Beckley (ATAI) share price and day range?
As of 19-08-2026, the ATAI Beckley share price is 7.355, with a previous close of 7.290. The share price has ranged from 7.270 to 7.370 today, while the 52-week range spans from 3.265 to 7.370.
What Is the ATAI Beckley Market Cap?
As of today, ATAI Beckley market cap is 2.730B.
What Is the ATAI Beckley (ATAI) Share Price Target?
The average 12-month share price target for ATAI Beckley is 8.100, with a high estimate of 9.25 and a low estimate of 7.45. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Neutral and +10.13% Upside potential.
What Is ATAI Beckley's Earnings Per Share (TTM)?
The ATAI Beckley EPS (TTM) is -2.136.
When Is the Next ATAI Beckley Earnings Date?
ATAI Beckley will release its next earnings report on 19-08-2026.
From a Technical Analysis Perspective, Is ATAI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does ATAI Beckley Trade On?
ATAI Beckley is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for ATAI Beckley?
The stock symbol for ATAI Beckley is "ATAI."
How Many Times Has ATAI Beckley Stock Split?
ATAI Beckley has split 0 times.
How Many Employees Does ATAI Beckley Have?
ATAI Beckley has 99 employees.
What Is the ATAI Premarket Price?
ATAI's last pre-market stock price is 7.270. The pre-market share volume is 32,390.000, and the stock has changed by -0.020, or -0.270%.
What Is the ATAI After Hours Price?
ATAI's last after hours stock price is 7.330, the stock has changed by -0.030, or -0.410%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.